Introduction of lamivudine for the treatment of chronic hepatitis B: Expected clinical and economic outcomes based on 4-year clinical trial data
- 1 February 2002
- journal article
- research article
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 17 (2) , 153-164
- https://doi.org/10.1046/j.1440-1746.2002.02673.x
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Effects of extended lamivudine therapy in Asian patients with chronic hepatitis BGastroenterology, 2000
- Cost-Effectiveness Analysis of Lamivudine for the Treatment of Chronic Hepatitis BPharmacoEconomics, 2000
- Lamivudine treatment for decompensated cirrhosis due to hepatitis B: A multicenter longitudinal studyGastroenterology, 2000
- Lamivudine and alpha interferon combination treatment of patients with chronic hepatitis B infection: a randomised trialGut, 2000
- Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis BHepatology, 2000
- Lamivudine as Initial Treatment for Chronic Hepatitis B in the United StatesNew England Journal of Medicine, 1999
- Therapy of Viral HepatitisDigestion, 1998
- A One-Year Trial of Lamivudine for Chronic Hepatitis BNew England Journal of Medicine, 1998
- Epidemiology of hepatitis B infection in the Western Pacific and South East Asia.Gut, 1996
- Effect of Alpha-Interferon Treatment in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis BAnnals of Internal Medicine, 1993